Insmed, Inc. (INSM)
126.63
+5.12
(+4.21%)
USD |
NASDAQ |
Sep 02, 16:00
126.90
+0.27
(+0.21%)
After-Hours: 06:47
Insmed Net Income (Annual) : -1.277B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.277B |
| December 31, 2024 | -913.77M |
| December 31, 2023 | -749.57M |
| December 31, 2022 | -481.53M |
| December 31, 2021 | -434.65M |
| December 31, 2020 | -294.09M |
| December 31, 2019 | -254.34M |
| December 31, 2018 | -324.28M |
| December 31, 2017 | -192.65M |
| December 31, 2016 | -176.27M |
| December 31, 2015 | -118.18M |
| December 31, 2014 | -79.16M |
| December 31, 2013 | -56.07M |
| December 31, 2012 | -41.37M |
| Date | Value |
|---|---|
| December 31, 2011 | -68.84M |
| December 31, 2010 | -6.434M |
| December 31, 2009 | 118.35M |
| December 31, 2008 | -15.67M |
| December 31, 2007 | -19.96M |
| December 31, 2006 | -56.14M |
| December 31, 2005 | -40.93M |
| December 31, 2004 | -27.20M |
| December 31, 2003 | -10.30M |
| December 31, 2002 | -36.42M |
| December 31, 2001 | -37.17M |
| December 31, 2000 | -79.86M |
| December 31, 1999 | -19.10M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Biogen, Inc. | 1.293B |
| Gilead Sciences, Inc. | 8.51B |
| Agios Pharmaceuticals, Inc. | -412.78M |